Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

MLA

Gunnarsson, Martin, et al. “Axonal Damage in Relapsing Multiple Sclerosis Is Markedly Reduced by Natalizumab.” Annals of Neurology, vol. 69, no. 1, Jan. 2011, pp. 83–89. EBSCOhost, https://doi.org/10.1002/ana.22247.

APA

Gunnarsson, M., Malmeström, C., Axelsson, M., Sundström, P., Dahle, C., Vrethem, M., Olsson, T., Piehl, F., Norgren, N., Rosengren, L., Svenningsson, A., & Lycke, J. (2011). Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. Annals of Neurology, 69(1), 83–89. https://doi.org/10.1002/ana.22247

Chicago

Gunnarsson, Martin, Clas Malmeström, Markus Axelsson, Peter Sundström, Charlotte Dahle, Magnus Vrethem, Tomas Olsson, et al. 2011. “Axonal Damage in Relapsing Multiple Sclerosis Is Markedly Reduced by Natalizumab.” Annals of Neurology 69 (1): 83–89. doi:10.1002/ana.22247.